Akumentis Healthcare Launches Epilepsy Drug: Clasepi
Akumentis Healthcare launches Clasepi, a cannabidiol (CBD) drug for epilepsy treatment, targeting Lennox-Gastaut, Dravet, and Tuberous Sclerosis in patients aged 1 year and older.
Jan 10, 2024 15:58